Related Experiment Video
Updated: Jul 19, 2026
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Long-term survival in metastatic pancreatic cancer. A case report and review of the literature
Gian Paolo Spinelli1, Angelo Zullo, Adriana Romiti
1Department of Experimental Medicine and Pathology, La Sapienza University, Rome, Italy.
Context:
Pancreatic cancer still remains an incurable disease. The survival rate of patients in all stages of the disease is poor. Overall median survival is 3-5 months with a 12-month survival rate of 10% and a 5-year survival rate less than 5%.
Case Report:
We report a rare case of a long-term survivor (more than 10 years) of metastatic carcinoma of the pancreas tail controlled with subsequent surgical and chemotherapeutic strategies with an acceptable performance status and quality of life.
Discussion:
This is the fifth case reported in the literature showing that long-term survival may be achieved even in advanced pancreatic cancer.
